Active, Not Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma
NCT05646836
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Peter Maccallum Cancer Centre Melbourne, Victoria, Australia
- Alfred Hospital Melbourne, Victoria, Australia
- Sygehus Lillebaelt - Vejle Sygehus Vejle, Denmark